CIK: 0001952142 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 13, 2024
Total Value ($000): $340,279 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,412,176 | $28,992 | 8.5% | $16.60 | +26.1% | COM | 87164F105 |
| ROIV | ROIVANT SCIENCES LTD | 2,712,741 | $28,674 | 8.4% | $10.15 | +8.0% | SHS | G76279101 |
| IMVT | IMMUNOVANT INC | 1,011,879 | $26,714 | 7.9% | $33.53 | -15.2% | COM | 45258J102 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 551,095 | $24,684 | 7.3% | $35.72 | +29.3% | COM | 22663K107 |
| — | MERUS N V | 288,668 | $17,080 | 5.0% | $33.51 | — | COM | N5749R100 |
| ACLX | ARCELLX INC | 280,709 | $15,492 | 4.6% | $49.74 | +9.3% | COMMON STOCK | 03940C100 |
| FOLD | AMICUS THERAPEUTICS INC | 1,495,047 | $14,831 | 4.4% | $11.99 | -14.4% | COM | 03152W109 |
| IMCR | IMMUNOCORE HLDGS PLC | 339,351 | $11,501 | 3.4% | $33.89 | — | ADS | 45258D105 |
| — | APPLIED THERAPEUTICS INC | 2,211,320 | $10,327 | 3.0% | $5.20 | — | COM | 03828A101 |
| MRK | MERCK & CO INC | 81,508 | $10,153 | 3.0% | $121.72 | 0.0% | COM | 58933Y105 |
| GSK | GSK PLC | 245,933 | $9,468 | 2.8% | $38.50 | — | SPONSORED ADR | 37733W204 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 2,662,732 | $9,266 | 2.7% | $6.39 | — | SPON ADS | 05280R100 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 965,392 | $8,978 | 2.6% | $2.72 | +232.7% | COM | 03969K108 |
| CABA | CABALETTA BIO INC | 1,178,105 | $8,812 | 2.6% | $18.32 | -33.1% | COM | 12674W109 |
| KALV | KALVISTA PHARMACEUTICALS INC | 736,765 | $8,679 | 2.6% | $11.79 | -1.0% | COM | 483497103 |
| BHVN | BIOHAVEN LTD | 233,255 | $8,096 | 2.4% | $36.52 | +8.3% | COM | G1110E107 |
| VTGN | VISTAGEN THERAPEUTICS INC | 1,848,582 | $5,848 | 1.7% | $3.82 | +13.5% | COM | 92840H400 |
| IMTX | IMMATICS N.V | 502,207 | $5,836 | 1.7% | $9.25 | +21.8% | SHS | N44445109 |
| DNLI | DENALI THERAPEUTICS INC | 251,010 | $5,828 | 1.7% | $19.20 | 0.0% | COM | 24823R105 |
| INSM | INSMED INC | 86,980 | $5,828 | 1.7% | $26.68 | +45.4% | COM PAR $.01 | 457669307 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 144,467 | $5,347 | 1.6% | $37.73 | 0.0% | COM NEW | 15117B202 |
| LRMR | LARIMAR THERAPEUTICS INC | 704,349 | $5,107 | 1.5% | $3.37 | +127.0% | COM | 517125100 |
| TCRX | TSCAN THERAPEUTICS INC | 845,069 | $4,944 | 1.5% | $7.88 | 0.0% | COM | 89854M101 |
| EWTX | EDGEWISE THERAPEUTICS INC | 271,057 | $4,882 | 1.4% | $17.44 | 0.0% | COM | 28036F105 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 101,479 | $4,592 | 1.3% | $42.06 | 0.0% | COM NEW | 21833P301 |
| FULC | FULCRUM THERAPEUTICS INC | 696,464 | $4,318 | 1.3% | $5.94 | +27.6% | COM | 359616109 |
| NRIX | NURIX THERAPEUTICS INC | 203,273 | $4,242 | 1.2% | $15.57 | 0.0% | COM | 67080M103 |
| PYXS | PYXIS ONCOLOGY INC | 1,202,675 | $3,981 | 1.2% | $4.21 | -0.0% | COMMON STOCK | 747324101 |
| JANX | JANUX THERAPEUTICS INC | 92,949 | $3,894 | 1.1% | $21.78 | +115.6% | COM | 47103J105 |
| IDYA | IDEAYA BIOSCIENCES INC | 101,787 | $3,574 | 1.1% | $42.52 | -6.9% | COM | 45166A102 |
| SYRE | SPYRE THERAPEUTICS INC | 150,450 | $3,537 | 1.0% | $25.47 | +32.4% | COM NEW | 00773J202 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 343,810 | $3,428 | 1.0% | $14.46 | 0.0% | COM NEW | 46489V302 |
| JSPR | JASPER THERAPEUTICS INC | 143,775 | $3,264 | 1.0% | $18.39 | +30.4% | COM NEW | 471871202 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 674,198 | $3,142 | 0.9% | $5.37 | 0.0% | COM | 09203E105 |
| — | VIGIL NEUROSCIENCE INC | 744,412 | $2,978 | 0.9% | $4.00 | — | COM | 92673K108 |
| NGNE | NEUROGENE INC | 78,601 | $2,860 | 0.8% | $35.27 | 0.0% | COM | 64135M105 |
| SLN | SILENCE THERAPEUTICS PLC | 124,866 | $2,372 | 0.7% | $19.00 | — | ADS | 82686Q101 |
| TARA | PROTARA THERAPEUTICS INC | 984,113 | $2,047 | 0.6% | $2.98 | -1.7% | COM STK | 74365U107 |
| BBOT | HELIX ACQUISITION CORP II | 200,000 | $2,044 | 0.6% | $10.35 | -0.6% | CL A ORD SHS | G4444H101 |
| SRZN | SURROZEN INC | 143,510 | $1,571 | 0.5% | $10.32 | 0.0% | COM NEW | 86889P208 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 150,000 | $1,509 | 0.4% | $10.07 | 0.0% | CL A ORD SHS | G70077105 |
| PRAX | PRAXIS PRECISION MEDICINES I | 29,259 | $1,210 | 0.4% | $45.06 | +4.9% | COM NEW | 74006W207 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 500,000 | $350 | 0.1% | $2.72 | +232.7% | Call | 03969K108 |